Works about VACCINE trials
Results: 1109
VACCINATION DES CANARDS CONTRE L'INFLUENZA AVIAIRE HAUTEMENT PATHOGÈNE: ESTIMATION DE L'EFFICACITÉ VACCINALE ET COMPARAISON DE L'EFFICACITÉ DES STRATÉGIES DE SURVEILLANCE.
- Published in:
- Épidémiologie et Santé Animale, 2024, n. 83/84, p. 117
- By:
- Publication type:
- Article
Impact of prior dengue infection on severity and outcomes: meta-analysis of placebo-controlled trials.
- Published in:
- Pan American Journal of Public Health, 2024, v. 48, p. 1, doi. 10.26633/RPSP.2024.129
- By:
- Publication type:
- Article
The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention.
- Published in:
- International Journal of Neuropsychopharmacology, 2025, v. 28, n. 2, p. 1, doi. 10.1093/ijnp/pyaf005
- By:
- Publication type:
- Article
Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 187, doi. 10.3390/vaccines13020187
- By:
- Publication type:
- Article
Plasma microRNAs to Select Optimal Patients for Antibody Production from Anti-Addiction Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 181, doi. 10.3390/vaccines13020181
- By:
- Publication type:
- Article
Prevalence of Adverse Events Reported Following the First Dose of COVID-19 Vaccines in Bahia State, Brazil, from 2021 to 2022.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 161, doi. 10.3390/vaccines13020161
- By:
- Publication type:
- Article
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 133, doi. 10.3390/vaccines13020133
- By:
- Publication type:
- Article
Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 187, doi. 10.3390/vaccines13020187
- By:
- Publication type:
- Article
Plasma microRNAs to Select Optimal Patients for Antibody Production from Anti-Addiction Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 181, doi. 10.3390/vaccines13020181
- By:
- Publication type:
- Article
Prevalence of Adverse Events Reported Following the First Dose of COVID-19 Vaccines in Bahia State, Brazil, from 2021 to 2022.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 161, doi. 10.3390/vaccines13020161
- By:
- Publication type:
- Article
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 133, doi. 10.3390/vaccines13020133
- By:
- Publication type:
- Article
Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development.
- Published in:
- Computational & Mathematical Organization Theory, 2023, v. 29, n. 3, p. 448, doi. 10.1007/s10588-022-09370-3
- By:
- Publication type:
- Article
Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Vitamin E at a high dose as an anti‐ferroptosis drug and not just a supplement for COVID‐19 treatment.
- Published in:
- Biotechnology & Applied Biochemistry, 2022, v. 69, n. 3, p. 1058, doi. 10.1002/bab.2176
- By:
- Publication type:
- Article
Advances in molecular epidemiology and detection methods of pseudorabies virus.
- Published in:
- Discover Nano, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s11671-025-04217-7
- By:
- Publication type:
- Article
新冠候選疫苗之緊急授權: 對疫苗臨床試驗的整響.
- Published in:
- Angle Health Law Review, 2022, n. 70, p. 47, doi. 10.53106/241553062022080070005
- By:
- Publication type:
- Article
A brief overview of various vaccines against nCOVID19, including safety, efficacy, reported cases, clinical trials, and progress.
- Published in:
- Indian Journal of Health Sciences & Biomedical Research KLEU, 2023, v. 16, n. 1, p. 13, doi. 10.4103/kleuhsj.kleuhsj_505_22
- By:
- Publication type:
- Article
Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00620-2
- By:
- Publication type:
- Article
Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00554-1
- By:
- Publication type:
- Article
Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liver.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00558-x
- By:
- Publication type:
- Article
Toxoplasmosis vaccines: what we have and where to go?
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00563-0
- By:
- Publication type:
- Article
Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00544-3
- By:
- Publication type:
- Article
An immunological autobiography: my year as a COVID-19 vaccine trial participant.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00502-z
- By:
- Publication type:
- Article
Publisher Correction: An immunological autobiography: my year as a COVID-19 vaccine trial participant.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
An immunological autobiography: my year as a COVID-19 vaccine trial participant.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00502-z
- By:
- Publication type:
- Article
Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00483-z
- By:
- Publication type:
- Article
Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00483-z
- By:
- Publication type:
- Article
Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00470-4
- By:
- Publication type:
- Article
Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00453-5
- By:
- Publication type:
- Article
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00436-6
- By:
- Publication type:
- Article
Preimmunization correlates of protection shared across malaria vaccine trials in adults.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-021-00425-1
- By:
- Publication type:
- Article
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00419-z
- By:
- Publication type:
- Article
VOE: automated analysis of variant epitopes of SARS-CoV-2 for the development of diagnostic tests or vaccines for COVID-19.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17504
- By:
- Publication type:
- Article
Pharmacists' vaccine basic knowledge and attitudes in the RN Macedonia.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 449, doi. 10.33320/maced.pharm.bull.2022.68.03.216
- By:
- Publication type:
- Article
Optimal Control Applied to Vaccination and Testing Policies for COVID-19.
- Published in:
- Mathematics (2227-7390), 2021, v. 9, n. 23, p. 3100, doi. 10.3390/math9233100
- By:
- Publication type:
- Article
Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.
- Published in:
- African Journal of Laboratory Medicine, 2021, v. 10, n. 1, p. 1, doi. 10.4102/ajlm.v10i1.1056
- By:
- Publication type:
- Article
Tackling inequalities in research.
- Published in:
- Biologist, 2022, v. 69, n. 4, p. 10
- By:
- Publication type:
- Article
Factors associated with vaccine default in Southern Ghana based on data from the RTSS malaria vaccine trial in Cape Coast.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-75408-y
- By:
- Publication type:
- Article
The disappearing COVID-Naïve Population and comparative Roche vs. Abbott Test sensitivity: evidence from antibody seroprevalence in Milwaukee County, Wisconsin.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-76946-1
- By:
- Publication type:
- Article
The disappearing COVID-Naïve Population and comparative Roche vs. Abbott Test sensitivity: evidence from antibody seroprevalence in Milwaukee County, Wisconsin.
- Published in:
- Scientific Reports, 2024, v. 12, n. 1, p. 1, doi. 10.1038/s41598-024-76946-1
- By:
- Publication type:
- Article
The History and Science of the Major Birch Pollen Allergen Bet v 1.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 7, p. 1151, doi. 10.3390/biom13071151
- By:
- Publication type:
- Article
Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 3, p. 407, doi. 10.3390/biom11030407
- By:
- Publication type:
- Article
Consideraciones éticas sobre los ensayos de vacunas controlados con placebo en mujeres embarazadas.
- Published in:
- Revista Bioetica, 2023, v. 31, n. 1, p. 1, doi. 10.1590/1983-803420233205ES
- By:
- Publication type:
- Article
Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study.
- Published in:
- Pathogens & Global Health, 2023, v. 117, n. 2, p. 152, doi. 10.1080/20477724.2022.2091862
- By:
- Publication type:
- Article
Utility, limitations, and future of non-human primates for dengue research and vaccine development.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00452
- By:
- Publication type:
- Article
Identification of protective antigens for vaccination against systemic salmonellosis.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00381
- By:
- Publication type:
- Article
Análisis bibliométrico de evidencia científica de vacunas (Sputnik V, Moderna, Pfizer, Sinopharm, AstraZeneca, Janssen) para Covid-19.
- Published in:
- Gaceta Médica Boliviana, 2022, v. 45, n. 2, p. 167, doi. 10.47993/gmb.v45i2.223
- By:
- Publication type:
- Article
Comparative Study of SERS-Spectra of NQ21 Peptide on Silver Particles and in Gold-Coated "Nanovoids".
- Published in:
- Biosensors (2079-6374), 2023, v. 13, n. 9, p. 895, doi. 10.3390/bios13090895
- By:
- Publication type:
- Article
Field Investigation Evaluating the Efficacy of Porcine Reproductive and Respiratory Syndrome Virus Type 2 (PRRSV-2) Modified Live Vaccines in Nursery Pigs Exposed to Multiple Heterologous PRRSV Strains.
- Published in:
- Animals (2076-2615), 2025, v. 15, n. 3, p. 428, doi. 10.3390/ani15030428
- By:
- Publication type:
- Article
An Investigation of Virulence Genes of Staphylococcus aureus in Autologous Vaccines Against Sheep Mastitis.
- Published in:
- Animals (2076-2615), 2024, v. 14, n. 22, p. 3172, doi. 10.3390/ani14223172
- By:
- Publication type:
- Article